Ludovica Vanzan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ludovica Vanzan has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- David Michael Suter
EPFL
2 shared publications - Rabih Murr
Department of Genetic Medicine and Development, University of Geneva Medical School, Geneva, Switzerland
2 shared publications - Ana Claudia Marques
Department of Computational Biology, University of Lausanne, Lausanne, Switzerland
1 shared publication - Andrea Iannello
Department of Clinical and Biological Sciences, University of Turin, Turin, Italy
1 shared publication Athena Sklias
1 shared publicationCedric Deluz
Ecole Polytechnique Federale de Lausanne, School of Life Sciences, Institute of Bioengineering, Lausanne, Switzerland
1 shared publication
Latest Publications
- Open Access
STAT transcription factors regulate host defences and vacuolar integrity during Mycobacterium marinum infection
Signal transducers and activators of transcription (STAT) are central regulators of cytokine-mediated immunity in metazoans, yet their ancestral functions prior to the emergence of interferon signalling remain poorly understood. Dictyostelium discoideum expresses four STAT-like factors that impact the intracellular fate of Mycobacterium marinum (Mm). Using dst knockout strains, we identify DstA and DstB as susceptibility factors, whereas DstC acts as a resistance factor, revealing a regulatory axis controlling the integrity of the Mm-containing vacuole (MCV). Despite the absence of canonical cytokine receptors and JAK kinases, DstA rapidly translocates to the nucleus in a damage-dependent manner, whereas DstB and DstC exhibit delayed cytosolic redistribution. DstA associates with VacA, a membrane microdomain component, regulates its transcription and accumulation at the MCV, while VacA acts as a cytoplasmic anchor that limits DstA nuclear translocation. Our findings establish STAT-like proteins as evolutionarily ancient regulators of vacuole integrity and host defence, providing new insights into the origins of STAT-mediated immune responses during mycobacterial infection.
Open AccessSTAT transcription factors regulate host defences and vacuolar integrity during Mycobacterium marinum infection
Signal transducers and activators of transcription (STAT) are central regulators of cytokine-mediated immunity in metazoans, yet their ancestral functions prior to the emergence of interferon signalling remain poorly understood. Dictyostelium discoideum expresses four STAT-like factors that impact the intracellular fate of Mycobacterium marinum (Mm). Using dst knockout strains, we identify DstA and DstB as susceptibility factors, whereas DstC acts as a resistance factor, revealing a regulatory axis controlling the integrity of the Mm-containing vacuole (MCV). Despite the absence of canonical cytokine receptors and JAK kinases, DstA rapidly translocates to the nucleus in a damage-dependent manner, whereas DstB and DstC exhibit delayed cytosolic redistribution. DstA associates with VacA, a membrane microdomain component, regulates its transcription and accumulation at the MCV, while VacA acts as a cytoplasmic anchor that limits DstA nuclear translocation. Our findings establish STAT-like proteins as evolutionarily ancient regulators of vacuole integrity and host defence, providing new insights into the origins of STAT-mediated immune responses during mycobacterial infection.
- Open Access
The role of charge, hydrophobicity, and cooperativity in target search of SOX2 and ESRRB
Transcription factors (TFs) locate and bind specific DNA sequences within a crowded nuclear environment, yet how their biophysical properties and interactions influence their search remains unclear. Here, we modulate hydrophobicity and charge of the pluripotency TFs SOX2 and ESRRB, and combine single-molecule imaging with genomic analyses to dissect their target search dynamics. We show that increased hydrophobicity impairs specific binding while promoting confined intranuclear interactions, whereas additional negative charges decrease sampling of weak binding sites. While SOX2 retains effective target site recognition despite decreased search efficiency, impairment of ESRRB search results in a global loss of genome occupancy and redirection to SOX2-bound regions, indicating a strong reliance of ESRRB on TF-TF interactions for locating its binding sites. Single molecule imaging analysis of ESRRB search upon SOX2 depletion demonstrated that SOX2 reduces ESRRB search time by restricting its nuclear diffusion and facilitating stable DNA binding. Together, our findings highlight how TF biophysical features and cooperativity jointly shape the efficiency and specificity of target search in the nucleus.
Open AccessThe role of charge, hydrophobicity, and cooperativity in target search of SOX2 and ESRRB
Transcription factors (TFs) locate and bind specific DNA sequences within a crowded nuclear environment, yet how their biophysical properties and interactions influence their search remains unclear. Here, we modulate hydrophobicity and charge of the pluripotency TFs SOX2 and ESRRB, and combine single-molecule imaging with genomic analyses to dissect their target search dynamics. We show that increased hydrophobicity impairs specific binding while promoting confined intranuclear interactions, whereas additional negative charges decrease sampling of weak binding sites. While SOX2 retains effective target site recognition despite decreased search efficiency, impairment of ESRRB search results in a global loss of genome occupancy and redirection to SOX2-bound regions, indicating a strong reliance of ESRRB on TF-TF interactions for locating its binding sites. Single molecule imaging analysis of ESRRB search upon SOX2 depletion demonstrated that SOX2 reduces ESRRB search time by restricting its nuclear diffusion and facilitating stable DNA binding. Together, our findings highlight how TF biophysical features and cooperativity jointly shape the efficiency and specificity of target search in the nucleus.
- Open Access
Orchestration of pluripotent stem cell genome reactivation during mitotic exit
Summary: The maintenance of cell identity faces many challenges during mitosis, as most DNA-binding proteins are evicted from DNA and transcription is virtually abolished. How cells maintain their identity through cell division and faithfully re-initiate gene expression during mitotic exit is unclear. Here, we developed a novel reporter system enabling cell cycle synchronization-free separation of pluripotent stem cells in temporal bins of < 30 minutes during mitotic exit. This allowed us to quantify genome-wide reactivation of transcription, sequential changes in chromatin accessibility, and re-binding of the pluripotency transcription factors OCT4, SOX2, and NANOG (OSN). We found that transcriptional activity progressively ramped up after mitosis and that OSN rapidly reoccupied the genome during the anaphase-telophase transition. We also demonstrate transcription factor-specific, dynamic relocation patterns and a hierarchical reorganization of the OSN binding landscape governed by OCT4 and SOX2. Our study sheds light on the dynamic orchestration of transcriptional reactivation after mitosis.
Open AccessOrchestration of pluripotent stem cell genome reactivation during mitotic exit
Summary: The maintenance of cell identity faces many challenges during mitosis, as most DNA-binding proteins are evicted from DNA and transcription is virtually abolished. How cells maintain their identity through cell division and faithfully re-initiate gene expression during mitotic exit is unclear. Here, we developed a novel reporter system enabling cell cycle synchronization-free separation of pluripotent stem cells in temporal bins of < 30 minutes during mitotic exit. This allowed us to quantify genome-wide reactivation of transcription, sequential changes in chromatin accessibility, and re-binding of the pluripotency transcription factors OCT4, SOX2, and NANOG (OSN). We found that transcriptional activity progressively ramped up after mitosis and that OSN rapidly reoccupied the genome during the anaphase-telophase transition. We also demonstrate transcription factor-specific, dynamic relocation patterns and a hierarchical reorganization of the OSN binding landscape governed by OCT4 and SOX2. Our study sheds light on the dynamic orchestration of transcriptional reactivation after mitosis.
- Open Access
- 7 June 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-18
High throughput screening identifies SOX2 as a super pioneer factor that inhibits DNA methylation maintenance at its binding sites
Binding of mammalian transcription factors (TFs) to regulatory regions is hindered by chromatin compaction and DNA methylation of their binding sites. Nevertheless, pioneer transcription factors (PFs), a distinct class of TFs, have the ability to access nucleosomal DNA, leading to nucleosome remodelling and enhanced chromatin accessibility. Whether PFs can bind to methylated sites and induce DNA demethylation is largely unknown. Using a highly parallelized approach to investigate PF ability to bind methylated DNA and induce DNA demethylation, we show that the interdependence between DNA methylation and TF binding is more complex than previously thought, even within a select group of TFs displaying pioneering activity; while some PFs do not affect the methylation status of their binding sites, we identified PFs that can protect DNA from methylation and others that can induce DNA demethylation at methylated binding sites. We call the latter super pioneer transcription factors (SPFs), as they are seemingly able to overcome several types of repressive epigenetic marks. Finally, while most SPFs induce TET-dependent active DNA demethylation, SOX2 binding leads to passive demethylation, an activity enhanced by the co-binding of OCT4. This finding suggests that SPFs could interfere with epigenetic memory during DNA replication.
- 7 June 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-18
Open AccessHigh throughput screening identifies SOX2 as a super pioneer factor that inhibits DNA methylation maintenance at its binding sites
Binding of mammalian transcription factors (TFs) to regulatory regions is hindered by chromatin compaction and DNA methylation of their binding sites. Nevertheless, pioneer transcription factors (PFs), a distinct class of TFs, have the ability to access nucleosomal DNA, leading to nucleosome remodelling and enhanced chromatin accessibility. Whether PFs can bind to methylated sites and induce DNA demethylation is largely unknown. Using a highly parallelized approach to investigate PF ability to bind methylated DNA and induce DNA demethylation, we show that the interdependence between DNA methylation and TF binding is more complex than previously thought, even within a select group of TFs displaying pioneering activity; while some PFs do not affect the methylation status of their binding sites, we identified PFs that can protect DNA from methylation and others that can induce DNA demethylation at methylated binding sites. We call the latter super pioneer transcription factors (SPFs), as they are seemingly able to overcome several types of repressive epigenetic marks. Finally, while most SPFs induce TET-dependent active DNA demethylation, SOX2 binding leads to passive demethylation, an activity enhanced by the co-binding of OCT4. This finding suggests that SPFs could interfere with epigenetic memory during DNA replication.
- Open Access
- 3 July 2020
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 6 (27) , eaaz4012
Three-dimensional chromatin interactions remain stable upon CAG/CTG repeat expansion
Expanded CAG/CTG repeats underlie 13 neurological disorders, including myotonic dystrophy type 1 (DM1) and Huntington’s disease (HD). Upon expansion, disease loci acquire heterochromatic characteristics, which may provoke changes to chromatin conformation and thereby affect both gene expression and repeat instability. Here, we tested this hypothesis by performing 4C sequencing at the DMPK and HTT loci from DM1 and HD–derived cells. We find that allele sizes ranging from 15 to 1700 repeats displayed similar chromatin interaction profiles. This was true for both loci and for alleles with different DNA methylation levels and CTCF binding. Moreover, the ectopic insertion of an expanded CAG repeat tract did not change the conformation of the surrounding chromatin. We conclude that CAG/CTG repeat expansions are not enough to alter chromatin conformation in cis. Therefore, it is unlikely that changes in chromatin interactions drive repeat instability or changes in gene expression in these disorders.
- 3 July 2020
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 6 (27) , eaaz4012
Open AccessThree-dimensional chromatin interactions remain stable upon CAG/CTG repeat expansion
Expanded CAG/CTG repeats underlie 13 neurological disorders, including myotonic dystrophy type 1 (DM1) and Huntington’s disease (HD). Upon expansion, disease loci acquire heterochromatic characteristics, which may provoke changes to chromatin conformation and thereby affect both gene expression and repeat instability. Here, we tested this hypothesis by performing 4C sequencing at the DMPK and HTT loci from DM1 and HD–derived cells. We find that allele sizes ranging from 15 to 1700 repeats displayed similar chromatin interaction profiles. This was true for both loci and for alleles with different DNA methylation levels and CTCF binding. Moreover, the ectopic insertion of an expanded CAG repeat tract did not change the conformation of the surrounding chromatin. We conclude that CAG/CTG repeat expansions are not enough to alter chromatin conformation in cis. Therefore, it is unlikely that changes in chromatin interactions drive repeat instability or changes in gene expression in these disorders.
- Open Access
- 1 June 2016
- Published by Frontiers Media SA in Frontiers in Cellular Neuroscience
- Vol. 10, 147
E2 Regulates Epigenetic Signature on Neuroglobin Enhancer-Promoter in Neuronal Cells
Estrogens are neuroprotective factors in several neurological diseases. Neuroglobin (NGB) is one of the estrogen target gene involved in neuroprotection, but little is known about its transcriptional regulation. Estrogen genomic pathway in gene expression regulation is mediated by estrogen receptors (ERα and ERβ) that bind to specific regulatory genomic regions. We focused our attention on E2-induced NGB expression in human differentiated neuronal cell lines (SK-N-BE and NT-2). Previously, using bioinformatics analysis we identified a putative enhancer in the first intron of NGB locus. Therefore, we observed that E2 increased the enrichment of the H3K4me3 epigenetic marks at the promoter and of the H3K4me1 and H3K27Ac at the intron enhancer. In these NGB regulatory regions, we found estrogen receptor alpha (ER) binding suggesting that ER may mediate chromatin remodeling to induce NGB expression upon E2 treatment. Altogether our data show that NGB expression is regulated by ERa binding on genomic regulatory regions supporting hormone therapy applications for the neuroprotection against neurodegenerative disease.
- 1 June 2016
- Published by Frontiers Media SA in Frontiers in Cellular Neuroscience
- Vol. 10, 147
Open AccessE2 Regulates Epigenetic Signature on Neuroglobin Enhancer-Promoter in Neuronal Cells
Estrogens are neuroprotective factors in several neurological diseases. Neuroglobin (NGB) is one of the estrogen target gene involved in neuroprotection, but little is known about its transcriptional regulation. Estrogen genomic pathway in gene expression regulation is mediated by estrogen receptors (ERα and ERβ) that bind to specific regulatory genomic regions. We focused our attention on E2-induced NGB expression in human differentiated neuronal cell lines (SK-N-BE and NT-2). Previously, using bioinformatics analysis we identified a putative enhancer in the first intron of NGB locus. Therefore, we observed that E2 increased the enrichment of the H3K4me3 epigenetic marks at the promoter and of the H3K4me1 and H3K27Ac at the intron enhancer. In these NGB regulatory regions, we found estrogen receptor alpha (ER) binding suggesting that ER may mediate chromatin remodeling to induce NGB expression upon E2 treatment. Altogether our data show that NGB expression is regulated by ERa binding on genomic regulatory regions supporting hormone therapy applications for the neuroprotection against neurodegenerative disease.